Associated Papers
CD40L Activates Platelet Integrin αIIbβ3 by Binding to the Allosteric Site (Site 2) in a KGD-Independent Manner and HIGM1 Mutations Are Clustered in the Integrin-Binding Sites of CD40L.
Takada YK et al.
Cells, 2023
Hyper IgM Syndrome: a Report from the USIDNET Registry.
Leven EA et al.
Journal of Clinical Immunology, 2016
Immunoglobulin class switch recombination deficiency type 1 or CD40 ligand deficiency: from bedside to bench and back again.
Hirbod-Mobarakeh A et al.
Expert Review of Clinical Immunology, 2014
Crystallographic and mutational analysis of the CD40-CD154 complex and its implications for receptor activation.
An HJ et al.
The Journal of Biological Chemistry, 2011
CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance.
Hervé M et al.
The Journal of Experimental Medicine, 2007
The structural basis of hyper IgM deficiency - CD40L mutations.
Thusberg J et al.
Protein Engineering, Design & Selection : Peds, 2007
CD154 variants associated with hyper-IgM syndrome can form oligomers and trigger CD40-mediated signals.
Garber E et al.
The Journal of Biological Chemistry, 1999
CD40 ligand mutants responsible for X-linked hyper-IgM syndrome associate with wild type CD40 ligand.
Seyama K et al.
The Journal of Biological Chemistry, 1999
Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome.
Seyama K et al.
Blood, 1998
Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction.
Bajorath J et al.
Biochemistry, 1995
Soluble CD40L activates soluble and cell-surface integrin αvβ3, α5β1, and α4β1 by binding to the allosteric ligand-binding site (site 2).
Takada YK et al.
The Journal of Biological Chemistry, 0
Select a paper to view details